The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Posts tagged with "Stocks to avoid."

Western Banks Report
July 13, 2009
Biotechnology Report
November 17, 2008
Marine Transportation Report
September 29, 2008
Transportation & Logistics Report
September 22, 2008
Telecommunications Services Report
September 3, 2007
Southeastern Banks Report
February 19, 2007
Specialty Pharmaceuticals Report
January 8, 2007
Telecom Services Report
September 25, 2006
Residential Construction Report
July 31, 2006
Healthcare Facilities & Healthcare Technology Report
April 17, 2006
Semiconductors Report
March 6, 2006
TWST Investing Strategies Report
July 26, 2004
Specialty Finance/Mortgage Finance Report
July 19, 2004
Biotechnology Issue
July 5, 2004
Enterprise Software Report
June 21, 2004
Canadian Technology Report
June 14, 2004
Wireless Services Report
June 7, 2004
Oil Services Report
May 31, 2004
Real Estate Investment Trusts Report
May 17, 2004
Restaurants Issue
May 4, 2004

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy